Bortezomib in Rejection of Kidney Transplants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the study is to assess the efficacy of bortezomib, in association with steroids, plasma exchange, and polyclonal intravenous immunoglobulins, in the treatment of chronic antibody mediated rejection due to donor specific anti-HLA antibodies, in kidney transplant recipients
Epistemonikos ID: 59601501478df8339f2afcb27f57a9dec7fdbfa5
First added on: May 12, 2024